Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat ointment in atopic dermatitis
2010-024279-14Phase 2Completed
- Sponsor
- Intendis
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mapracorat in atopic dermatitis (AD) (4 arms), sponsored by Intendis. Primary endpoint: Eczema Area and Severity Index (EASI). Started Feb 2011; status: completed.
02
Drugs
mapracorat
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2010-024279-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024279-14.